Therapy of a murine lymphoma with tumor-specific antiserum in combination with adriamycin, cyclophosphamide, or L-asparaginase.
Therapy of the 6C3HED lymphoma in syngeneic C3H/HeN mice was studied using tumor-specific antiserum in combination with adriamycin, cyclophosphamide, or L-asparaginase. Antiserum therapy is only effective in the control of small numbers of tumor cells, and cell cures were only obtained when this number did not exceed 5 x 10(5). Complete suppression of larger numbers of tumor cells (10(6) to 5 x 10(7)) could be achieved with the inclusion of chemotherapy at levels that reduced the tumor cell number to less than 10(5) in the case of L-asparaginase and less than 10(4) with cyclophosphamide and adriamycin. The differences in drug cooperative effectiveness are likely to be due to drug-induced impairment of macrophage mobilization to the tumor site.